Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_assertion type Assertion NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_head.
- NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_assertion description "[Sensitivity for high grade dysplasia (HSIL) and invasive cancer in the EGFR study was 100%; specificity was 73.3%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_provenance.
- NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_assertion evidence source_evidence_literature NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_provenance.
- NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_assertion SIO_000772 12102125 NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_provenance.
- NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_assertion wasDerivedFrom befree-20150227 NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_provenance.
- NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_assertion wasGeneratedBy ECO_0000203 NP369972.RAwBpSVW6rr5GvzpJn2derVBQl-pk30tNP6mVDmxvmi8I130_provenance.